NBY
Novabay Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Market Cap: 947 Thousand
Primary Exchange: NYSE MKT LLC
Website: http://novabay.com/
Shares Outstanding: 6.53 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.8176393491522617
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 3071 trading days
From: 2013-09-20 To: 2024-03-07
Lowest Point:
SVRA and HEB among premarket losers
via: SeekingAlpha at 2019-06-13 05:09:48:000
Savara (NASDAQ: SVRA ) -76% as Molgradex flunks late-stage aPAP study. More news on: Savara Inc., Hemispherx Biopharma, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more … read more...
Microcaps dominate midday movers
via: SeekingAlpha at 2019-06-12 08:39:07:000
Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N… read more...
PLAY leads after hours losers
via: SeekingAlpha at 2019-06-11 13:34:03:000
Gainers: MX +16.9% . AXGT +15.5% . MAT +8.7% . NBY +6.7% . NVTR +5.5% . More news on: MagnaChip Semiconductor Corporation, Axovant Gene Therapies Ltd., Mattel, Inc., Stocks on the move, , News on ETFs Read more … read more...
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
MT, ZYNE among premarket gainers
via: SeekingAlpha at 2019-06-11 05:21:22:000
Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...
Caseys General Stores among after hour gainers
via: SeekingAlpha at 2019-06-10 13:38:05:000
Gainers: NBY +20.3% . CASY +9.4% . KEG +3.5% . CHAP +3.2% . CXW +2.7% . More news on: NovaBay Pharmaceuticals, Inc., Casey's General Stores, Inc., Key Energy Services, Inc., Stocks on the move, , News on ETFs Read more … read more...
NovaBay launches Avenova direct on Amazon; shares up 224% premarket
via: SeekingAlpha at 2019-06-10 04:27:30:000
NovaBayPharmaceuticals'(NYSEMKT: NBY ) Avenova Direct is now available at affordable pricing and without a prescription on Amazon.com through the Companys new direct-to-consumer online channel. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stock… read more...
NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com
via: Business Wire at 2019-06-10 02:50:00:000
Original formulation of Avenova for the management of bacterial dry eye is now available at an affordable price without a prescription NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|